Peregrine

Tag: Peregrine

Peregrine Pharmaceuticals engaged in an Active Trade - NASDAQ:PPHM

Posted by david on February 8th, 2012

Peregrine Pharmaceuticals (NASDAQ:PPHM) is a clinical-stage biopharmaceutical company that develops and manufactures monoclonal antibodies for the treatment of cancer and viral infections. Peregrine Pharmaceuticals witnessed volume of 5.35 million shares during last trade however it holds an average trading capacity of 1.02 million shares.

Tags:

NASDAQ:PPHM, PPHM, Peregrine

Peregrine Pharmaceuticals Non Normal Trade in last session - NASDAQ:PPHM

Posted by david on January 24th, 2012

Peregrine Pharmaceuticals (NASDAQ:PPHM) is a clinical-stage biopharmaceutical company that develops and manufactures monoclonal antibodies for the treatment of cancer and viral infections. Peregrine Pharmaceuticals witnessed volume of 4.44 million shares during last trade however it holds an average trading capacity of 855,657 shares.

Tags:

NASDAQ:PPHM, PPHM, Peregrine

(AVOT, NVAX, PPHM, NLTX ) Stocks in Focus by PennyToBuck.com

Posted by PennyToBuck on April 5th, 2011

American Video Teleconferencing Corp. (AVOT)

Common Properties of the Rare Earths:

These common properties apply to both the lanthanides and actinides.

" The rare earths are silver, silvery-white, or gray metals.

" The metals have a high luster, but tarnish readily in air.

" The metals have high electrical conductivity.

Tags:

NASDAQ:NLTX, Nile Therapeutics, American Video Teleconferencing, AVOT, NASDAQ:PPHM, Nasdaq:NVAX, Novavax, Peregrine

PPHM, GRHU.OB, SIFY, PPWE.PK, EDGR, - CRWESelect.com Stock Report! Peregrine Pharmaceuticals, GreenHouse Holdings

Posted by CRWESelect Stoc... on March 11th, 2011

Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM), a clinical-stage biopharmaceutical company developing first-in-class monoclonal antibodies for the treatment of cancer and viral infections, announced the appointment of Kerstin B. Menander, M.D., Ph.D. as head of medical oncology. During Dr.